Skip to main content
Signal8

Lakefront Biotherapeutics NV (LKFT)

Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics. Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis. The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es, and maintains its headquarters in Mechelen, Belgium.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Lakefront Biotherapeutics N.V. logo

Lakefront Biotherapeutics N.V.

NASDAQ:LKFTHealthcare
+2.38%$34.79
CLOSED
AH$34.79+0.00%vs close
Mkt Cap$2.29B
EV-
Float65.9M
O/S65.9M
VOL293K sh
$ Vol$10.16M
RVOL1.09×
Inst Own48.1%
SI2.0%
Net Cash/Sh-
Dilution
Lakefront Biotherapeutics N.V. logoNASDAQ:LKFTClosed$34.79+2.38%
Short interest (FINRA)
2.0%
Oct 30 (18d)

Float 65.90M · Signal8 estimate from ownership filings

1.3M
Oct 30 (18d)prev 1.4M▼ 8.3%
5.96
Oct 30 (18d)prev 4.77▲ 24.9%
Borrow (IBKR)

The cost to borrow LKFT shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
25.9%
Nov 16 (1d)prev 74.6%▼ 48.7 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

3.5K
Oct 26 (22d)prev 3.6K▼ 2.7%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver24 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 20261.3M sh
Oct 15, 20261.4M sh
Sep 30, 20263.3M sh
Sep 15, 20263.4M sh
Aug 31, 20263.3M sh
Latest fails to deliver
DateShares failed
Oct 26, 20263.5K sh
Oct 23, 20263.6K sh
Oct 22, 20262 sh
Oct 21, 2026289 sh
Oct 20, 2026288 sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 16
Latest sessions
DateReported short
Nov 16, 202625.9%
Nov 13, 202674.6%
Nov 12, 202667.2%
Nov 11, 202670.6%
Nov 10, 202669.8%
90-session median 62.9%mean 61.4%range 21.1–87.7%

130 calendar days requested; 91 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for LKFT: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 1,299,291 LKFT shares were sold short (1.97% of a 65.90M-share float, 5.96 days to cover).